Exelixis (EXEL) Tops Q1 EPS by 10c, provides guidance
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $54.08 +0.73%
Financial Fact:
Total other income (expense), net: 749K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total other income (expense), net: 749K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q1 EPS of $0.87, $0.10 better than the analyst estimate of $0.77. Revenue for the quarter came in at $610.8 million versus the consensus estimate of $608.95 million.
GUIDANCE:
Exelixis sees FY2026 revenue of $2.525-2.625 billion, versus the consensus of $2.583 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- Goldman Sachs Downgrades AAC Technologies Holdings Inc. (2018:HK) (AACAY) to Neutral
- loanDepot receives NYSE non-compliance notice over stock price
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
